Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe Street, Baltimore, MD, 21205, USA.
Department of Oncology, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, 21205, USA.
Breast Cancer Res Treat. 2023 Jun;199(3):565-582. doi: 10.1007/s10549-023-06948-6. Epub 2023 Apr 24.
To determine if disparities exist in survivorship care experiences among older breast cancer survivors by breast cancer characteristics, race/ethnicity, and socioeconomic factors.
A total of 19,017 female breast cancer survivors (≥ 65 at post-diagnosis survey) contributed data via SEER-CAHPS data linkage (2000-2019). Analyses included overall and stratified multivariable linear regression to estimate beta (β) coefficients and standard errors (SE) to identify relationships between clinical cancer characteristics and survivorship care experiences.
Minority survivors were mostly non-Hispanic (NH)-Black (8.1%) or NH-Asian (6.5%). Survivors were 76.3 years (SD = 7.14) at CAHPS survey and were 6.10 years (SD = 3.51) post-diagnosis on average. Survivors with regional breast cancer vs. localized at diagnosis (β = 1.00, SE = 0.46, p = 0.03) or treated with chemotherapy vs. no chemotherapy/unknown (β = 1.05, SE = 0.48, p = 0.03) reported higher mean scores for Getting Needed Care. Results were similar for Overall Care Ratings (β = 0.87, SE = 0.38, p = 0.02) among women treated with chemotherapy. Conversely, women diagnosed with distant breast cancer vs. localized reported lower mean scores for Physician Communication (β = - 1.94, SE = 0.92, p = 0.03). Race/ethnicity, education, and area-level poverty significantly modified several associations between stage, estrogen receptor status, treatments, and various CAHPS outcomes.
These study findings can be used to inform survivorship care providers treating women diagnosed with more advanced stage and aggressive disease. The disparities we observed among minority groups and by socioeconomic status should be further evaluated in future research as these interactions could impact long-term outcomes, including survival.
通过乳腺癌特征、种族/族裔和社会经济因素,确定老年乳腺癌幸存者的生存护理体验是否存在差异。
共有 19017 名女性乳腺癌幸存者(诊断后调查时≥65 岁)通过 SEER-CAHPS 数据链接(2000-2019 年)提供数据。分析包括总体和分层多变量线性回归,以估计β(β)系数和标准误差(SE),以确定临床癌症特征与生存护理体验之间的关系。
少数族裔幸存者主要是非西班牙裔(NH)-黑人(8.1%)或 NH-亚裔(6.5%)。幸存者在 CAHPS 调查时的年龄为 76.3 岁(SD=7.14),平均诊断后 6.10 年(SD=3.51)。与诊断时局限性乳腺癌相比,区域性乳腺癌(β=1.00,SE=0.46,p=0.03)或接受化疗与未接受化疗/未知(β=1.05,SE=0.48,p=0.03)的幸存者报告获得所需护理的平均评分更高。接受化疗的女性中,总体护理评分(β=0.87,SE=0.38,p=0.02)的结果相似。相反,与诊断为局限性乳腺癌相比,诊断为远处乳腺癌的女性报告的医生沟通评分较低(β=-1.94,SE=0.92,p=0.03)。种族/族裔、教育和地区贫困水平显著改变了分期、雌激素受体状态、治疗方法和各种 CAHPS 结果之间的几种关联。
这些研究结果可用于为治疗更晚期和侵袭性疾病的女性提供生存护理提供者。我们观察到的少数群体和社会经济地位之间的差异应在未来的研究中进一步评估,因为这些相互作用可能会影响包括生存在内的长期结果。